GOSS: Gossamer Bio Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Gossamer Bio Inc (GOSS).
$204.99M Market Cap.
GOSS Market Cap. (MRY)
GOSS Shares Outstanding (MRY)
GOSS Assets (MRY)
Total Assets
$315.29M
Total Liabilities
$285.80M
Total Investments
$248.44M
GOSS Income (MRY)
Revenue
$114.70M
Net Income
-$56.53M
Operating Expense
$174.62M
GOSS Cash Flow (MRY)
CF Operations
-$3.47M
CF Investing
$29.02M
CF Financing
-$11.49M
GOSS Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $315,292,000 (1.08%) | $311,916,000 (14.49%) | $272,450,000 (-20.72%) | $343,657,000 (-36.29%) |
Assets Current | $309,888,000 (1.10%) | $306,519,000 (17.05%) | $261,880,000 (-21.07%) | $331,780,000 (-36.48%) |
Assets Non-Current | $5,404,000 (0.13%) | $5,397,000 (-48.94%) | $10,570,000 (-11.00%) | $11,877,000 (-30.59%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $29,492,000 (-53.02%) | $62,769,000 (419.74%) | $12,077,000 (-90.06%) | $121,463,000 (-62.12%) |
Property Plant & Equipment Net | $5,121,000 (7.16%) | $4,779,000 (-51.68%) | $9,890,000 (-8.40%) | $10,797,000 (-32.87%) |
Cash & Equivalents | $46,074,000 (43.49%) | $32,109,000 (-71.32%) | $111,973,000 (-38.97%) | $183,467,000 (-62.30%) |
Accumulated Other Comprehensive Income | $1,189,000 (439.71%) | -$350,000 (39.02%) | -$574,000 (-1375.56%) | $45,000 (-92.49%) |
Deferred Revenue | $55,919,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Investments | $248,444,000 (-6.00%) | $264,316,000 (83.93%) | $143,705,000 (1.33%) | $141,815,000 (433.68%) |
Investments Current | $248,444,000 (-6.00%) | $264,316,000 (83.93%) | $143,705,000 (1.33%) | $141,815,000 (433.68%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $5,338,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Payables | $2,319,000 (-58.03%) | $5,526,000 (278.75%) | $1,459,000 (-55.02%) | $3,244,000 (-56.79%) |
Accumulated Retained Earnings (Deficit) | -$1,268,568,000 (-4.66%) | -$1,212,040,000 (-17.42%) | -$1,032,223,000 (-27.19%) | -$811,534,000 (-40.52%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $201,921,000 (-3.46%) | $209,162,000 (-6.10%) | $222,756,000 (22.17%) | $182,335,000 (1.24%) |
Debt Current | $0 (0%) | $11,613,000 (0.00%) | $11,613,000 (0%) | $0 (0%) |
Debt Non-Current | $201,921,000 (2.21%) | $197,549,000 (-6.44%) | $211,143,000 (15.80%) | $182,335,000 (1.24%) |
Total Liabilities | $285,800,000 (14.71%) | $249,147,000 (-4.31%) | $260,373,000 (17.18%) | $222,194,000 (1.57%) |
Liabilities Current | $45,010,000 (-12.77%) | $51,598,000 (4.81%) | $49,230,000 (23.51%) | $39,859,000 (3.13%) |
Liabilities Non-Current | $240,790,000 (21.89%) | $197,549,000 (-6.44%) | $211,143,000 (15.80%) | $182,335,000 (1.24%) |
GOSS Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $114,701,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $36,133,000 (-6.04%) | $38,455,000 (-19.23%) | $47,609,000 (3.99%) | $45,782,000 (-7.94%) |
Research & Development Expense | $138,487,000 (2.35%) | $135,304,000 (-20.84%) | $170,919,000 (0.38%) | $170,267,000 (5.85%) |
Operating Expenses | $174,620,000 (-4.97%) | $183,759,000 (-15.94%) | $218,593,000 (1.14%) | $216,124,000 (-7.62%) |
Interest Expense | $11,517,000 (-14.76%) | $13,511,000 (-2.66%) | $13,880,000 (-28.60%) | $19,440,000 (53.48%) |
Income Tax Expense | $893,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$56,528,000 (68.56%) | -$179,817,000 (21.61%) | -$229,378,000 (1.98%) | -$234,004,000 (3.84%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$56,528,000 (68.56%) | -$179,817,000 (21.61%) | -$229,378,000 (1.98%) | -$234,004,000 (3.84%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$56,528,000 (68.56%) | -$179,817,000 (21.61%) | -$229,378,000 (1.98%) | -$234,004,000 (3.84%) |
Weighted Average Shares | $226,228,016 (48.23%) | $152,621,669 (80.46%) | $84,574,869 (13.00%) | $74,843,482 (9.24%) |
Weighted Average Shares Diluted | $226,228,016 (48.23%) | $152,621,669 (80.46%) | $84,574,869 (13.00%) | $74,843,482 (9.24%) |
Earning Before Interest & Taxes (EBIT) | -$44,118,000 (73.47%) | -$166,306,000 (22.83%) | -$215,498,000 (-0.44%) | -$214,564,000 (6.99%) |
Gross Profit | $114,701,000 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$59,919,000 (67.39%) | -$183,759,000 (15.94%) | -$218,593,000 (-1.14%) | -$216,124,000 (7.62%) |
GOSS Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $29,023,000 (126.15%) | -$110,970,000 (-10621.74%) | -$1,035,000 (99.12%) | -$117,427,000 (-154.53%) |
Net Cash Flow from Financing | -$11,488,000 (-106.04%) | $190,154,000 (62.40%) | $117,090,000 (3417.27%) | $3,329,000 (-98.93%) |
Net Cash Flow from Operations | -$3,468,000 (97.82%) | -$159,158,000 (14.90%) | -$187,032,000 (0.98%) | -$188,890,000 (-7.10%) |
Net Cash Flow / Change in Cash & Cash Equivalents | $13,965,000 (117.49%) | -$79,864,000 (-11.71%) | -$71,494,000 (76.42%) | -$303,153,000 (-186.24%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | -$65,000 (13.33%) | -$75,000 (99.68%) |
Net Cash Flow - Investment Acquisitions and Disposals | $29,023,000 (126.15%) | -$110,970,000 (-19716.07%) | -$560,000 (99.52%) | -$115,806,000 (-148.21%) |
Capital Expenditure | $0 (0%) | $0 (0%) | -$410,000 (73.48%) | -$1,546,000 (-2.86%) |
Issuance (Repayment) of Debt Securities | -$12,581,000 (-8.34%) | -$11,613,000 (-100.02%) | -$5,806,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $1,093,000 (-99.46%) | $201,767,000 (64.18%) | $122,896,000 (3591.68%) | $3,329,000 (-97.20%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | -$102,000 (-192.73%) | $110,000 (121.28%) | -$517,000 (-213.33%) | -$165,000 (-1933.33%) |
Share Based Compensation | $20,619,000 (-27.70%) | $28,518,000 (-32.98%) | $42,553,000 (32.94%) | $32,008,000 (-17.39%) |
Depreciation Amortization & Accretion | $4,151,000 (-5.34%) | $4,385,000 (-0.99%) | $4,429,000 (-14.28%) | $5,167,000 (21.06%) |
GOSS Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 100.00% | - | - | - |
Profit Margin | -49.30% | - | - | - |
EBITDA Margin | -34.80% | - | - | - |
Return on Average Equity (ROAE) | -117.80% (87.53%) | -944.80% (15.43%) | -1117.20% (-835.68%) | -119.40% (-74.05%) |
Return on Average Assets (ROAA) | -17.40% (74.34%) | -67.80% (15.99%) | -80.70% (-41.83%) | -56.90% (-23.97%) |
Return on Sales (ROS) | -38.50% | - | - | - |
Return on Invested Capital (ROIC) | -10.20% (76.61%) | -43.60% (32.09%) | -64.20% (20.94%) | -81.20% (10.18%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -3.62 (-368.05%) | -0.77 (3.50%) | -0.8 (77.83%) | -3.61 (-32.64%) |
Price to Sales Ratio (P/S) | 1.78 | - | - | - |
Price to Book Ratio (P/B) | 6.95 (112.11%) | 3.28 (-80.70%) | 16.98 (138.43%) | 7.12 (210.92%) |
Debt to Equity Ratio (D/E) | 9.69 (144.17%) | 3.97 (-81.59%) | 21.56 (1078.73%) | 1.83 (168.18%) |
Earnings Per Share (EPS) | -0.25 (78.81%) | -1.18 (56.46%) | -2.71 (13.42%) | -3.13 (11.83%) |
Sales Per Share (SPS) | 0.51 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -0.01 (98.56%) | -1.04 (52.93%) | -2.22 (12.89%) | -2.54 (2.00%) |
Book Value Per Share (BVPS) | 0.13 (-68.37%) | 0.41 (187.41%) | 0.14 (-91.19%) | 1.62 (-65.33%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.39 (-31.80%) | 2.04 (-36.54%) | 3.22 (-29.86%) | 4.59 (-41.68%) |
Enterprise Value Over EBIT (EV/EBIT) | -9 (-350.00%) | -2 (-100.00%) | -1 (75.00%) | -4 (-100.00%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -9.47 (-356.73%) | -2.07 (-64.39%) | -1.26 (68.28%) | -3.98 (-99.30%) |
Asset Turnover | 0.35 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 6.88 (15.89%) | 5.94 (11.67%) | 5.32 (-36.09%) | 8.32 (-38.40%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$3,468,000 (97.82%) | -$159,158,000 (15.09%) | -$187,442,000 (1.57%) | -$190,436,000 (-7.07%) |
Enterprise Value (EV) | $378,400,102 (12.73%) | $335,681,999 (26.16%) | $266,079,658 (-68.04%) | $832,597,536 (84.31%) |
Earnings Before Tax (EBT) | -$55,635,000 (69.06%) | -$179,817,000 (21.61%) | -$229,378,000 (1.98%) | -$234,004,000 (3.84%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$39,967,000 (75.32%) | -$161,921,000 (23.29%) | -$211,069,000 (-0.80%) | -$209,397,000 (7.52%) |
Invested Capital | $426,129,000 (-2.57%) | $437,371,000 (30.95%) | $334,003,000 (10.35%) | $302,666,000 (55.80%) |
Working Capital | $264,878,000 (3.91%) | $254,921,000 (19.88%) | $212,650,000 (-27.15%) | $291,921,000 (-39.64%) |
Tangible Asset Value | $315,292,000 (1.08%) | $311,916,000 (14.49%) | $272,450,000 (-20.72%) | $343,657,000 (-36.29%) |
Market Capitalization | $204,986,102 (-0.34%) | $205,685,999 (0.33%) | $205,014,658 (-76.29%) | $864,802,536 (17.78%) |
Average Equity | $47,969,750 (152.04%) | $19,032,500 (-7.30%) | $20,531,500 (-89.53%) | $196,012,250 (-44.77%) |
Average Assets | $324,744,750 (22.37%) | $265,373,250 (-6.60%) | $284,127,750 (-30.94%) | $411,418,500 (-22.38%) |
Invested Capital Average | $432,215,000 (13.21%) | $381,773,500 (13.79%) | $335,517,500 (27.01%) | $264,172,250 (3.55%) |
Shares | 226,604,137 (0.53%) | 225,409,314 (138.59%) | 94,476,801 (23.56%) | 76,463,531 (0.71%) |
